Inderparasth Medical longInderparast Medical Daily Demand 465
Inderparast Medical 240 Demand 465
All Trend Upside
Target 600
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
15.10INR
1.24 BINR
12.45 BINR
37.94 M
About INDRAPRASTHA MEDICAL CORP
Sector
Industry
CEO
Shivakumar Pattabhiraman
Website
Headquarters
New Delhi
Employees (FY)
2.98 K
Founded
1988
ISIN
INE681B01017
FIGI
BBG000BVQN81
Indraprastha Medical Corp. Ltd. engages in the healthcare business. It operates through the following segments: Healthcare Deliveries, Pharma, and Medical Technologies and Others. The company was founded on March 16, 1988 and is headquartered in New Delhi, India.
Indramedco - Increasing MomentumIndraprastha Medical Corporation Ltd.
Crossing All Time High
Increasing Relative Strength
High Volume & Delivery
Disclaimer:
For educational purpose only.
Please do your own research before taking any trades.
Happy Trading!
INDRAMEDCO - BULLISH SETUPStock name = Indraprastha Medical Corprration Limited.
Weekly chart setup
Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined.
Master Score - B
Disclaimer: This is for dem
INDRAPRASTHA MEDICAL CORP - A good reversal bet for 15% ROI.The stock has given a fantastic rally , yearly breakout of 22 years in 2023.
The stock has been taking strong support at 165 levels since 4 months.
Now it shows reversal from 165 levels. Confirmed by price action - RSI.
Entry - 194.
Targets - 204, 208, 216,225.
It would be great to trail the pr
Regular Flat : Elliott Wave Correction Regular Flat : Elliott Wave Correction
Identified By student which shows the complete formation of Elliott wave flat correction
which is following basic the rule of subdivision of wave as 335 .
Although Find the basic rule for flat correction for your prectice :
REGULAR FLAT :
1- A Cor
Chart of the weakIndraprastha medical
1)considering weakly chart.
2) runaway gap at two area one at 73 level and another one at 100
3) Cup with handle pattern also breakout at level of 100
4) huge potential to give great return
5) take Stop loss of 99 and move ahead of 60+ upside
*No recommendation for buy or sel
Indraprastha MedicoMulti year BO of a microcap stock that is related to medical industry where pharma sector also started showing the reversal signs.
Positives:
Long term trendline breakout
Gann box level breakout
RSI above 65
MACD showing strength
BUY INDRAPRASTHA MEDICOBuy above 85
Sell at 95 103
Exit below 77 on daily closing basis
Book profits accordingly.
INDRAMEDCONSE:INDRAMEDCO
Please note that we are not a SEBI Registered Investor Adviser/PMS/ Broking House.
All the contents over here are for educational purposes only and are not investment advice or recommendations
offered to any person(s) with respect to the purchase or sale of the stocks / futures an
See all ideas
Frequently Asked Questions
The current price of INDRAMEDCO is 455.05 INR — it has decreased by −0.24% in the past 24 hours. Watch INDRAPRASTHA MEDICAL CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange INDRAPRASTHA MEDICAL CORP stocks are traded under the ticker INDRAMEDCO.
INDRAMEDCO stock has fallen by −3.39% compared to the previous week, the month change is a 26.75% rise, over the last year INDRAPRASTHA MEDICAL CORP has showed a 185.30% increase.
INDRAMEDCO reached its all-time high on Sep 13, 2024 with the price of 484.00 INR, and its all-time low was 5.00 INR and was reached on Feb 22, 1999. View more price dynamics on INDRAMEDCO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
INDRAMEDCO stock is 3.68% volatile and has beta coefficient of −0.26. Track INDRAPRASTHA MEDICAL CORP stock price on the chart and check out the list of the most volatile stocks — is INDRAPRASTHA MEDICAL CORP there?
Today INDRAPRASTHA MEDICAL CORP has the market capitalization of 41.81 B, it has decreased by −5.54% over the last week.
Yes, you can track INDRAPRASTHA MEDICAL CORP financials in yearly and quarterly reports right on TradingView.
INDRAPRASTHA MEDICAL CORP is going to release the next earnings report on Nov 5, 2024. Keep track of upcoming events with our Earnings Calendar.
INDRAMEDCO net income for the last quarter is 447.70 M INR, while the quarter before that showed 311.70 M INR of net income which accounts for 43.63% change. Track more INDRAPRASTHA MEDICAL CORP financial stats to get the full picture.
Yes, INDRAMEDCO dividends are paid annually. The last dividend per share was 4.50 INR. As of today, Dividend Yield (TTM)% is 0.66%. Tracking INDRAPRASTHA MEDICAL CORP dividends might help you take more informed decisions.
INDRAPRASTHA MEDICAL CORP dividend yield was 2.62% in 2023, and payout ratio reached 33.28%. The year before the numbers were 3.86% and 31.92% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 20, 2024, the company has 2.98 K employees. See our rating of the largest employees — is INDRAPRASTHA MEDICAL CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INDRAPRASTHA MEDICAL CORP EBITDA is 2.13 B INR, and current EBITDA margin is 15.73%. See more stats in INDRAPRASTHA MEDICAL CORP financial statements.
Like other stocks, INDRAMEDCO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INDRAPRASTHA MEDICAL CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INDRAPRASTHA MEDICAL CORP technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INDRAPRASTHA MEDICAL CORP stock shows the strong buy signal. See more of INDRAPRASTHA MEDICAL CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.